Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-24

Clinical Trial Update: Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) [EARLY_Phase 1]

View source ↗

Summary

The EARLY Phase 1 feasibility study on metabolic and functional derangement in primary mitral regurgitation using Carbon-11 acetate PET-MRI has been withdrawn (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Mitral Valve Regurgitation | EARLY_Phase 1 | Status: WITHDRAWN